Kinpo Electronics Inc. Acquired EU Medical Certificate for Wearable ECG Monitor: BC1 Patch

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

CE MDD grants XYZlife BC1 – the wearable ECG device, to launch in Europe as medical products.

Globally, CVD is the number 1 cause of death; which represents 30% of global death. Kinpo Electronics Inc. provisioned future burden caused to people.  Kinpo Electronics Inc. has developed a solution for CVD prevention. Today they announced acquirement of medical CE MDD certificate for its in-house developed wearable ECG monitor, BC1 Patch. CE MDD (Medical Device Directive 93/42/EEC) certification allows BC1 to be marketed directly to consumers within the European Union, and Kinpo Electronics Inc. will start marketing in major European territories by Q3 2017, under its own brand, XYZlife.


Simon Shen, CEO of Kinpo Electronics Inc.,  said, “I am so proud of the medical team! It is indeed a great leap and encouragement that the vision of future medical field, especially telemedicine which will benefit the world to solve aging problems.  He continued, “We truly believe one of the most important parts for future healthcare is telemedicine. Along with mobile network enhancement, we will be able to collect and monitor patients’ status on real-time basis.”

The company describes the BC1 Patch as an innovative wearable ECG monitor which provides long term & real-time monitoring, historical observation and dedicated reports for medical professionals and users. A unique calling function can  immediately contact doctors, family or a close friend when irregular signs are detected. It also helps individuals and doctors, from pre-screening potential cardiac symptoms to efficient treatment and outpatient medical care.



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.